Jessica R. Terrill

The University of Western Australia — Australia

Biochemistry, Genetics and Molecular Biology · Life Sciences

16h-index1.2kcitations43works0.92yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Muscle Physiology and Disorders(30), Muscle metabolism and nutrition(18), Exercise and Physiological Responses(18), Adipose Tissue and Metabolism(17), Nitric Oxide and Endothelin Effects(2)

Publications43 total

286PEvaluating a panel of plasma biomarkers of DMD in taurine-treated juvenile mdx mice
Neuromuscular Disorders·2025
Development of capillary electrophoresis method to measure albumin thiol oxidation in dystrophic humans and animal models of Duchenne muscular dystrophy
Methods·2025Open Access
282P Biomarker panel for Duchenne muscular dystrophy clinical trials
Neuromuscular Disorders·2024
Oxidised Albumin Levels in Plasma and Skeletal Muscle as Biomarkers of Disease Progression and Treatment Efficacy in Dystrophic mdx Mice
Antioxidants·2024· 1 citedOpen Access
Antenatal creatine supplementation reduces persistent fetal lung inflammation and oxidative stress in an ovine model of chorioamnionitis
American Journal of Physiology-Lung Cellular and Molecular Physiology·2024· 4 cited
Quantification of tissue creatine content using capillary electrophoresis
2024Open Access
Quantification of tissue creatine content using capillary electrophoresis v1
2024· 1 citedOpen Access
Dimethyl fumarate modulates the dystrophic disease program following short-term treatment
JCI Insight·2023· 12 citedOpen Access
Muscle Pathology in Dystrophic Rats and Zebrafish Is Unresponsive to Taurine Treatment, Compared to the mdx Mouse Model for Duchenne Muscular Dystrophy
Metabolites·2023· 3 citedOpen Access
The location of protein oxidation in dystrophic skeletal muscle from the mdx mouse model of Duchenne muscular dystrophy
Acta Histochemica·2022· 5 cited
Dimethyl fumarate modulates the Duchenne muscular dystrophy disease program following short-term treatment in <i>mdx</i> mice
2022· 1 citedOpen Access
A Blood Biomarker for Duchenne Muscular Dystrophy Shows That Oxidation State of Albumin Correlates with Protein Oxidation and Damage in Mdx Muscle
Antioxidants·2021· 14 citedOpen Access
Oxidative damage to urinary proteins from the GRMD dog and mdx mouse as biomarkers of dystropathology in Duchenne muscular dystrophy
PLoS ONE·2020· 8 citedOpen Access
Biomarkers for Duchenne muscular dystrophy: myonecrosis, inflammation and oxidative stress
Disease Models & Mechanisms·2020· 124 citedOpen Access
Investigation of the effect of taurine supplementation on muscle taurine content in the mdx mouse model of Duchenne muscular dystrophy using chemically specific synchrotron imaging
The Analyst·2020· 10 citedOpen Access
DMD ANIMAL MODELS
Neuromuscular Disorders·2019· 1 cited
Expression patterns of regulatory RNAs, including lncRNAs and tRNAs, during postnatal growth of normal and dystrophic (mdx) mouse muscles, and their response to taurine treatment
The International Journal of Biochemistry & Cell Biology·2018· 8 cited
Reply from Gavin J. Pinniger, Jessica R. Terrill, Miranda D. Grounds and Peter G. Arthur
The Journal of Physiology·2018Open Access
Beneficial effects of high dose taurine treatment in juvenile dystrophic mdx mice are offset by growth restriction
PLoS ONE·2017· 25 citedOpen Access
Taurine: an anti-inflammatory and antioxidant with strong potential benefits for Duchenne muscular dystrophy
Neuromuscular Disorders·2017· 2 cited
page 1 of 3Next →

Frequent Co-authors

Peter G. Arthur(33), Miranda D. Grounds(30), Hannah G. Radley‐Crabb(8), Gavin J. Pinniger(8), Tea Shavlakadze(7), Angelo Bautista(7), Basma A. Al-Mshhdani(4), Marisa N. Duong(4), Irene Tsioutsias(4), Tomohito Iwasaki(3), Zoe White(3), Robert B. White(3), Y. Jane Choi(3), J. Jane Pillow(3), Christopher McMahon(2), Phillip Sheard(2), Terry Robertson(2), J. M. Papadimitriou(2), Simone Spuler(2), Caroline Le Guiner(2)